Rizatriptan Benzoate Tablet, Orally Disintegrating
Product Images NDC 69452-157

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 69452-157). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bionpharma Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 01

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 02

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 03

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 04

This appears to be a pharmaceutical-related document talking about two types of tablets called "Benzoyl Peroxide Oral Disintegrating Tablets" and "Rasuvastatin Calcium Oral Disintegrating Tablets". The document also shows a graph with two lines representing the effect of the tablets at different hours post-dose. Without proper context, it is difficult to determine the purpose of the graph.*

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 05

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 06

Product Name: Rizatriptan Benzoate Orally Disintegrating Tablets, USP 5 mg. The peelable lidding foil item code is PBFR034C with a change control number of BCC245/20. The foil width is 132mm with colors of black and Pantone 300C. Blister size is 96x38mm, with a print repeat length of 98.033-98.116mm and an eyemark size of 3x5mm. The pitch after the 6th mark is 588.2-588.7mm. The tablets are designed for oral disintegration and can be used to treat migraines. The product is intended for sale in the USA.*

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 07

This is a packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets. It includes information such as the product name, size, item code, market, and colors for the label. The label also features a revision number for the packaging. However, there is some unclear text which is not readable due to errors.*

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 08

This text contains information related to the packaging of Rizatriptan Benzoate orally disintegrating tablets. The text includes details such as the item code, change control number, foil width, blister size, print repeat length, and pitch after 6th mark. The product name, Rizatriptan Benzoate Orally Disintegrating Tablets, is also mentioned. There are markings indicating space for coding, and red lines that are not to be printed.*

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 09

This is a product description of the Rizatriptan Benzoate Orally Disintegrating Tablets, USP 10 mg. The tablets come in a black and Pantone 300C colored box with dimensions of 108(L)x30(W)x42(H) mm. It is intended for use in the US market and comes in a size of 18 unit-dose (6 blisters of 3 Unit-dose (1 x 3)) Orally Disintegrating Tablets. The text includes some gibberish characters and a description of the packaging but no further information on the product or its use.*

FDA Label Image

Cfdcf7ff E979 444f B9fe 68fb3e9495b9 88 1

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.